Doi.org/10.1016/j.bbrc.2017.07.139
Revision as of 13:07, 4 August 2022 by 179.215.124.0 (talk) (Created page with "== Target Article == BEBT-908: A novel potent PI3K/HDAC inhibitor against diffuse large B-cell lymphoma ; Jin Li Changgeng Qian Qianqian Zhou Jiwei Li Kunlun Li Pingyong Yi; NULL; 07/26/2017; https://doi.org/10.1016/j.bbrc.2017.07.139 == Reasons == Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.")
Target ArticleEdit
BEBT-908: A novel potent PI3K/HDAC inhibitor against diffuse large B-cell lymphoma ; Jin Li Changgeng Qian Qianqian Zhou Jiwei Li Kunlun Li Pingyong Yi; NULL; 07/26/2017; https://doi.org/10.1016/j.bbrc.2017.07.139
ReasonsEdit
Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.